Berry Global Announces Major Healthcare Investment in India

Berry Global Group, Inc. (NYSE: BERY) is again demonstrating its worldwide leadership in the design, development, and production of patient-centered healthcare solutions with the announcement of plans to establish a second manufacturing facility and global healthcare center of excellence in Bangalore, India.

Planned for development near Berry’s existing Bangalore operation, the new facility will enable the company to extend its R&D expertise and scale up production in several key healthcare sectors: ophthalmic, nasal pumps, inhalation, and injectable administrations. The increased capacity will also enhance supply in India and throughout South Asia, addressing some of the fastest growing healthcare market geographies.

“Investing in our global healthcare business in Bangalore is a significant step in supporting our pharmaceutical, over-the-counter, and medical device customers aligned to forecasted market needs,” remarked Tom Salmon, Berry Global’s Chairman and CEO. “During the pandemic, we’ve learned that strategically placed facilities across the world provide efficient localized support for customers of any size. We believe this investment significantly benefits the India and South Asia patient populations.”
more at:

Back To Top
×Close search